These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22432119)

  • 1. Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD).
    McEwen LN; Karter AJ; Waitzfelder BE; Crosson JC; Marrero DG; Mangione CM; Herman WH
    Diabetes Care; 2012 Jun; 35(6):1301-9. PubMed ID: 22432119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study.
    McEwen LN; Kim C; Karter AJ; Haan MN; Ghosh D; Lantz PM; Mangione CM; Thompson TJ; Herman WH
    Diabetes Care; 2007 Jul; 30(7):1736-41. PubMed ID: 17468353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.
    Andersson C; van Gaal L; Caterson ID; Weeke P; James WP; Coutinho W; Finer N; Sharma AM; Maggioni AP; Torp-Pedersen C
    Diabetologia; 2012 Sep; 55(9):2348-55. PubMed ID: 22638548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus.
    Rhodes ET; Prosser LA; Hoerger TJ; Lieu T; Ludwig DS; Laffel LM
    Diabet Med; 2012 Apr; 29(4):453-63. PubMed ID: 22150528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
    Khaw KT; Wareham N; Bingham S; Luben R; Welch A; Day N
    Ann Intern Med; 2004 Sep; 141(6):413-20. PubMed ID: 15381514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis.
    Vazquez-Benitez G; Desai JR; Xu S; Goodrich GK; Schroeder EB; Nichols GA; Segal J; Butler MG; Karter AJ; Steiner JF; Newton KM; Morales LS; Pathak RD; Thomas A; Reynolds K; Kirchner HL; Waitzfelder B; Elston Lafata J; Adibhatla R; Xu Z; O'Connor PJ
    Diabetes Care; 2015 May; 38(5):905-12. PubMed ID: 25710922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
    Niskanen L; Turpeinen A; Penttilä I; Uusitupa MI
    Diabetes Care; 1998 Nov; 21(11):1861-9. PubMed ID: 9802734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal T; Hemmingsen C; Wetterslev J
    BMJ; 2011 Nov; 343():d6898. PubMed ID: 22115901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA1c 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes.
    Kerr D; Partridge H; Knott J; Thomas PW
    Diabet Med; 2011 Dec; 28(12):1520-4. PubMed ID: 21913968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes.
    Christiansen MS; Hommel E; Magid E; Feldt-Rasmussen B
    Diabetologia; 2002 Jan; 45(1):115-20. PubMed ID: 11845230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
    Triebswetter S; Gutjahr-Lengsfeld LJ; Schmidt KR; Drechsler C; Wanner C; Krane V
    Am J Nephrol; 2018; 47(1):30-39. PubMed ID: 29320770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.
    Yu D; Shang J; Cai Y; Wang Z; Zhang X; Zhao B; Zhao Z; Simmons D
    BMJ Open Diabetes Res Care; 2019; 7(1):e000735. PubMed ID: 31798896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
    Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
    Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.
    Sharif S; Van der Graaf Y; Cramer MJ; Kapelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Cardiovasc Diabetol; 2021 Nov; 20(1):220. PubMed ID: 34753497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Walking decreased risk of cardiovascular disease mortality in older adults with diabetes.
    Smith TC; Wingard DL; Smith B; Kritz-Silverstein D; Barrett-Connor E
    J Clin Epidemiol; 2007 Mar; 60(3):309-17. PubMed ID: 17292026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2008 Apr; 31(4):714-9. PubMed ID: 18083789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study.
    Lee JH; Han K; Huh JH
    Cardiovasc Diabetol; 2020 Apr; 19(1):44. PubMed ID: 32238157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.